Association of Urinary Bisphenol A concentration with medical disorders and laboratory abnormalities in adults

JAMA

Volumn 300, Issue 11, 2008, Pages 1303-1310

  Lang, Iain A ^a   Galloway, Tamara S ^b   Scarlett, Alan ^b   Henley, William E ^c   Depledge, Michael ^a   Wallace, Robert B ^d   Melzer, David ^a  

^a PENINSULA MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF EXETER   (United Kingdom)

^c UNIVERSITY OF PLYMOUTH   (United Kingdom)

^d UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL;

ABNORMAL LABORATORY RESULT; ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; CARDIOVASCULAR DISEASE; CREATININE URINE LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HEALTH HAZARD; HEALTH STATUS; HUMAN; INFLAMMATION; LIVER FUNCTION; LONG TERM EXPOSURE; MALE; PRIORITY JOURNAL; UNITED STATES; URINE LEVEL;

EID: 51949106158     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.300.11.1303     Document Type: Article

References (44)

1. Burridge E. Bisphenol A: product profile. Eur Chem News. 2003;78(2048):17.
2. Calafat AM, Kuklenyik Z, Reidy JA, Caudill SP, Ekong J, Needham LL. Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ Health Perspect. 2005;113(4):391-395.
3. Calafat AM, Ye X, Wong LY, Reidy JA, Needham LL. Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004. Environ Health Perspect. 2008;116(1):39-44.
4. Vandenberg LN, Hauser R, Marcus M, Olea N, Welshons WV. Human exposure to bisphenol A (BPA). Reprod Toxicol. 2007;24(2):139-177.
5. Takeuchi T, Tsutsumi O, Ikezuki Y, Takai Y, Taketani Y. Positive relationship between androgen and the endocrine disruptor, bisphenol A, in normal women and women with ovarian dysfunction. Endocr J. 2004;51(2):165-169.
6. Okada H, Tokunaga T, Liu X, Takayanagi S, Matsushima A, Shimohigashi Y. Direct evidence revealing structural elements essential for the high binding ability of bisphenol A to human estrogen-related receptor-gamma. Environ Health Perspect. 2008;116(1):32-38.
7. Bindhumol V, Chitra KC, Mathur PP. Bisphenol A induces reactive oxygen species generation in the liver of male rats. Toxicology. 2003;188(2-3):117-124.
8. Elsby R, Maggs JL, Ashby J, Park BK. Comparison of the modulatory effects of human and rat liver microsomal metabolism on the estrogenicity of bisphenol A: implications for extrapolation to humans. J Pharmacol Exp Ther. 2001;297(1):103-113.
9. Nakagawa Y, Tayama S. Metabolism and cytotoxicity of bisphenol A and other bisphenols in isolated rat hepatocytes. Arch Toxicol. 2000;74(2):99-105.
10. Roy D, Palangat M, Chen CW, et al. Biochemical and molecular changes at the cellular level in response to exposure to environmental estrogen-like chemicals. J Toxicol Environ Health. 1997;50(1):1-29.
11. Tyl RW, Myers CB, Marr MC, et al. Three-generation reproductive toxicity study of dietary bisphenol A in CD Sprague-Dawley rats. Toxicol Sci. 2002;68(1):121-146.
12. Ropero AB, Alonso-Magdalena P, Garcia-Garcia E, Ripoll C, Fuentes E, Nadal A. Bisphenol-A disruption of the endocrine pancreas and blood glucose homeostasis. Int J Androl. 2008;31(2):194-200.
13. Moriyama K, Tagami T, Akamizu T, et al. Thyroid hormone action is disrupted by bisphenol A as an antagonist. J Clin Endocrinol Metab. 2002;87(11):5185-5190.
14. Newbold RR, Padilla-Banks E, Jefferson WN, Heindel JJ. Effects of endocrine disruptors on obesity. Int J Androl. 2008;31(2):201-208.
15. Welshons WV, Nagel SC, vom Saal FS. Large effects from small exposures, III: endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology. 2006;147(6)(suppl):S56-S69.
16. European Union. European Union Risk Assessment Report: 4,4′-isopropylidenediphenol (bisphenol-A). Luxembourg, Belgium: Office for Official Publications of the European Communities; 2003. CAS No. 80-05-7; EINECS No. 201-245-8.
17. vom Saal FS, Hughes C. An extensive new literature concerning low-dose effects of bisphenol A shows the need for a new risk assessment. Environ Health Perspect. 2005;113(8):926-933.
18. vom Saal FS, Akingbemi BT, Belcher SM, et al. Chapel Hill bisphenol A expert panel consensus statement: integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure. Reprod Toxicol. 2007;24(2):131-138.
19. Goodman JE, McConnell EE, Sipes IG, et al. An updated weight of the evidence evaluation of reproductive and developmental effects of low doses of bisphenol A. Crit Rev Toxicol. 2006;36(5):387-457.
20. National Toxicology Program (NTP). Draft NTP brief on bisphenol A. http://cerhr.niehs.nih.gov/chemicals/bisphenol/BPADraftBriefVF_04_14_08.pdf. April 14, 2008. Accessibility verified August 19, 2008.
21. Dekant W, Volkel W. Human exposure to bisphenol A by biomonitoring: methods, results and assessment of environmental exposures. Toxicol Appl Pharmacol. 2008;228(1):114-134.
22. Centers for Disease Control and Prevention (CDC). National Health and Nutrition Examination Survey Data 2003-04. Hyattsville, MD: US Dept of Health and Human Services, CDC; 2004.
23. Centers for Disease Control and Prevention (CDC). Third National Report on Human Exposure to Environmental Chemicals. Altanta, GA: CDC; 2005.
24. Centers for Disease Control and Prevention (CDC). Bisphenol A and other environmental phenols in urine: NHANES 2003-2004. CDC Web site. http://www.cdc.gov/nchs/data/nhanes/nhanes_03_04/l24eph_c_met_phenols.pdf. May 25, 2005. Accessed May 2, 2008.
25. Diabetic Trials Unit, University of Oxford. HOMA calculator. University of Oxford Web site. http://www.dtu.ox.ac.uk/index.php?maindoc=/homa/. December 12, 2007. Accessibility verified August 19, 2008.
26. Korn E, Graubard B. Analysis of large health surveys: accounting for the sampling design. J R Stat Soc Ser A Stat Soc. 1995;158:263-295.
27. Barr DB, Wilder LC, Caudill SP, Gonzalez AJ, Needham LL, Pirkle JL. Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ Health Perspect. 2005;113(2):192-200.
28. National Health and Nutrition Examination Survey: lab methods 2003-2004. Centers for Disease Control and Prevention Web site. http://www.cdc.gov/nchs/ about/major/nhanes/nhanes2003-2004/lab_methods_03_04.htm. Accessibility verified August 19, 2008.
29. Hsieh FY, Bloch DA, Larsen MD. A simple method of sample size calculation for linear and logistic regression. Stat Med. 1998;17(14):1623-1634.
30. Dupont WD, Plummer WD Jr. Power and sample size calculations for studies involving linear regression. Control Clin Trials. 1998;19(6):589-601.
31. PS: power and sample size calculation. Vanderbilt University Web site. http://biostat.mc.vanderbilt.edu/twiki/bin/view/Main/PowerSampleSize. Accessibility verified August 19, 2008.
32. Oehlmann J, Schulte-Oehlmann U, Bachmann J, et al. Bisphenol A induces superfeminization in the ramshorn snail Marisa cornuarietis (Gastropoda: Prosobranchia) at environmentally relevant concentrations. Environ Health Perspect. 2006;114(suppl 1):127-133.
33. Teeguarden JG, Waechter JM Jr, Clewell HJ III, Covington TR, Barton HA. Evaluation of oral and intravenous route pharmacokinetics, plasma protein binding, and uterine tissue dose metrics of bisphenol A: a physiologically based pharmacokinetic approach. Toxicol Sci. 2005;85(2):823-838.
34. Matsumoto J, Yokota H, Yuasa A. Developmental increases in rat hepatic microsomal UDP-glucuronosyltransferase activities toward xenoestrogens and decreases during pregnancy. Environ Health Perspect. 2002;110(2):193-196.
35. Ouchi K, Watanabe S. Measurement of bisphenol A in human urine using liquid chromatography with multi-channel coulometric electrochemical detection. J Chromatogr B Analyt Technol Biomed Life Sci. 2002;780(2):365-370.
36. Matsumoto A, Kunugita N, Kitagawa K, et al. Bisphenol A levels in human urine. Environ Health Perspect. 2003;111(1):101-104.
37. Völkel W, Colnot T, Csanady GA, Filser JG, Dekant W. Metabolism and kinetics of bisphenol A in humans at low doses following oral administration. Chem Res Toxicol. 2002;15(10):1281-1287.
38. Mahalingaiah S, Meeker JD, Pearson KR, et al. Temporal variability and predictors of urinary bisphenol A concentrations in men and women. Environ Health Perspect. 2008;116(2):173-178.
39. Yoshihara S, Mizutare T, Makishima M, et al. Potent estrogenic metabolites of bisphenol A and bisphenol B formed by rat liver S9 fraction: their structures and estrogenic potency. Toxicol Sci. 2004;78(1):50-59.
40. Wada K, Sakamoto H, Nishikawa K, et al. Life style-related diseases of the digestive system: endocrine disruptors stimulate lipid accumulation in target cells related to metabolic syndrome. J Pharmacol Sci. 2007;105(2):133-137.
41. Alonso-Magdalena P, Morimoto S, Ripoll C, Fuentes E, Nadal A. The estrogenic effect of bisphenol A disrupts pancreatic beta-cell function in vivo and induces insulin resistance. Environ Health Perspect. 2006;114(1):106-112.
42. Lee DH, Lee IK, Song K, et al. A strong dose-response relation between serum concentrations of persistent organic pollutants and diabetes: results from the National Health and Examination Survey 1999-2002. Diabetes Care. 2006;29(7):1638-1644.
43. Vasiliu O, Cameron L, Gardiner J, Deguire P, Karmaus W. Polybrominated biphenyls, polychlorinated biphenyls, body weight, and incidence of adult-onset diabetes mellitus. Epidemiology. 2006;17(4):352-359.
44. Grün F, Blumberg B. Perturbed nuclear receptor signaling by environmental obesogens as emerging factors in the obesity crisis. Rev Endocr Metab Disord. 2007;8(2):161-171.